GURUFOCUS.COM » STOCK LIST » Technology » Software » Clarivate PLC (NYSE:CLVT) » Definitions » Debt-to-EBITDA

Clarivate (Clarivate) Debt-to-EBITDA : -1.98 (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Clarivate Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Clarivate's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $24 Mil. Clarivate's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $4,784 Mil. Clarivate's annualized EBITDA for the quarter that ended in Dec. 2023 was $-2,424 Mil. Clarivate's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -1.98.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Clarivate's Debt-to-EBITDA or its related term are showing as below:

CLVT' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -457.97   Med: 12.4   Max: 58.68
Current: -457.97

During the past 7 years, the highest Debt-to-EBITDA Ratio of Clarivate was 58.68. The lowest was -457.97. And the median was 12.40.

CLVT's Debt-to-EBITDA is ranked worse than
100% of 1601 companies
in the Software industry
Industry Median: 1.04 vs CLVT: -457.97

Clarivate Debt-to-EBITDA Historical Data

The historical data trend for Clarivate's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clarivate Debt-to-EBITDA Chart

Clarivate Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial 15.70 58.68 10.55 -1.70 -457.97

Clarivate Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.50 5.51 13.36 4.48 -1.98

Competitive Comparison of Clarivate's Debt-to-EBITDA

For the Information Technology Services subindustry, Clarivate's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clarivate's Debt-to-EBITDA Distribution in the Software Industry

For the Software industry and Technology sector, Clarivate's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Clarivate's Debt-to-EBITDA falls into.



Clarivate Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Clarivate's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(24.4 + 4784.3) / -10.5
=-457.97

Clarivate's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(24.4 + 4784.3) / -2423.6
=-1.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Clarivate  (NYSE:CLVT) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Clarivate Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Clarivate's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Clarivate (Clarivate) Business Description

Traded in Other Exchanges
Address
70 St. Mary Axe, London, GBR, EC3A 8BE
Clarivate PLC is an information, analytics, and workflow solutions company. It operates in three segments: Academia and Government; Life Sciences and Healthcare and Intellectual Property. The company generates maximum revenue from the Academia and Government segment. The A&G segment consists of Academia and Government product group, which drives research excellence across institutions, empower researchers to tackle today's global challenges and help academic institutions and libraries improve operational efficiency and effectiveness. Geographically, it derives a majority of its revenue from the Americas.
Executives
Melanie Margolin officer: Chief Legal Officer 1000 SAGAMORE PARKWAY SOUTH, LAFAYETTE IN 47905
Saurabh Saha director C/O CENTESSA PHARMACEUTICALS PLC, 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE X0 WA14 2DT
Henry Levy officer: President, LS&H 70 ST. MARY AXE, LONDON X0 EC3 8BA
Bar Veinstein officer: President, A&G 70 ST. MARY AXE, LONDON X0 EC3 8BA
James Gordon Samson officer: President, IP Group FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SE 1 8EZ
Andrew Miles Snyder director 111 WEST 57TH STREET, 9TH FLOOR, NEW YORK NY 10019
Wendell E. Pritchett director TOLL BROTHERS, INC., 1140 VIRGINIA DRIVE, FORT WASHINGTON PA 19034
Jonathan Gear director, officer: Chief Executive Officer-Elect C/O IHS MARKIT LTD., 4TH FLOOR, ROPEMAKE, 25 ROPEMAKER STREET, LONDON X0 EC2Y 9LY
Michael M Easton officer: Senior VP, Finance/CAO 4TH FLOOR ROPEMAKER PLACE, 25 ROPEMAKER STREET, LONDON X0 EC2Y 9LY
Stefano Maestri officer: Chief Technology Officer 70 ST MARY AXE, LONDON X0 EC3 8BA
Jonathan Mark Collins officer: Executive Vice President/CFO 50196 VENICE COURT, NORTHVILLE MI 48168
Mukhtar Ahmed officer: President, Science Group FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SEL 8EZ
Michael J Angelakis director 40 MORRIS AVENUE, BRYN MAWR PA 19010
Heather Matzke-hamlin officer: Acting Chief Acctg Officer 4TH FLOOR, ROPEMAKER PLACE, 25 ROPEMAKER STREET, LONDON X0 EC2Y 9LY
Steen Lomholt-thomsen officer: Chief Revenue Officer FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SE1 8EZ